Results 11 to 20 of about 65,290 (261)
Dystonia in atypical parkinsonian disorders [PDF]
Dystonia is common in the classic atypical parkinsonian disorders such as multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration, and to a lesser extent in dementia with Lewy bodies. Its clinical phenomenology, including body distribution, timing of appearance, severity, and relationship to dopaminergic and other ...
Marsili L. +5 more
openaire +5 more sources
Nocturnal Manifestations of Atypical Parkinsonian Disorders
Although nocturnal disturbances are increasingly recognized as an integral part of the continuum of daytime manifestations of Parkinson's disease (PD), there is still little evidence in the medical literature to support the occurrence of these complex ...
Roongroj Bhidayasiri +2 more
doaj +3 more sources
Atypical parkinsonian disorders
DOI:10.3969/j.issn.1672-6731.2011.01 ...
Yue HUANG +3 more
doaj +1 more source
Toward Biology-Driven Diagnosis of Atypical Parkinsonian Disorders. [PDF]
Atypical parkinsonian disorders—progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA)—are rare, rapidly progressive neurodegenerative syndromes characterized by distinct molecular pathologies ...
Arias-Carrión O +2 more
europepmc +2 more sources
TSPO imaging in parkinsonian disorders. [PDF]
Microglial activation is a key aspect of the neuroinflammatory process in neurodegenerative disorders including idiopathic and atypical parkinsonian disorders. With positron emission tomography (PET) it has become possible to image this phenomenon in vivo and over the last years patterns of microglia activation corresponding with the known distribution
Gerhard A.
europepmc +5 more sources
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. [PDF]
Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative ...
van Eimeren T +28 more
europepmc +2 more sources
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. [PDF]
Pereira JB +9 more
europepmc +2 more sources
Advanced diffusion imaging which accounts for complex tissue properties, such as crossing fibers and extracellular fluid, may detect longitudinal changes in widespread pathology in atypical Parkinsonian syndromes.
Trina Mitchell +18 more
doaj +1 more source
Increased bradykinesia in Parkinson’s disease with increased movement complexity: elbow flexion-extension movements [PDF]
The present research investigates factors contributing to bradykinesia in the control of simple and complex voluntary limb movement in Parkinson’s disease (PD) patients.
Geelen, J.A.G. +3 more
core +9 more sources
The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
The diagnosis of Parkinson's disease and atypical Parkinsonism remains clinically difficult, especially at the early stage of the disease, since there is a significant overlap of symptoms. Multimodal MRI has significantly improved diagnostic accuracy and
Lydia Chougar +14 more
doaj +1 more source

